Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxis

BACKGROUND: Chemotherapy-induced neutropenia increases the risk of febrile neutropenia (FN) and infection with resultant hospitalizations, with substantial health care resource utilization (HCRU) and costs. Granulocyte-colony stimulating factor (GCSF) is recommended as primary prophylaxis for chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslam, Saad, Li, Edward, Bell, Elizabeth, Lal, Lincy, Anderson, Amy J, Peterson-Brandt, Jesse, Lyman, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387928/
https://www.ncbi.nlm.nih.gov/pubmed/36705281
http://dx.doi.org/10.18553/jmcp.2023.29.2.128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387928/
https://www.ncbi.nlm.nih.gov/pubmed/36705281
http://dx.doi.org/10.18553/jmcp.2023.29.2.128

Ejemplares similares